Maven Brands Inc. (TRLFF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Jul 31, 2025
R1 RCM Market Cap
Maven Brands has a market cap or net worth of $517.04 thousand as of August 1, 2025. Its market cap has decreased by -90.62% in one year.
Market Cap
517.04K
Enterprise Value
4.90M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since October 23, 2015, Maven Brands's market cap has decreased from 4.04M to 517.04K, a decrease of -87.19%. That is a compound annual growth rate of -22.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2023 | 517.04K | 32.76% |
| Dec 30, 2022 | 389.47K | -89.95% |
| Dec 31, 2021 | 3.88M | -67.01% |
| Dec 31, 2020 | 11.75M | 15.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
| Oct 23, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.76B |
| Veradigm | 794.80M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 563.22M |
| Glass House Brands | 409.73M |
| Nika Pharmaceuticals | 366.89M |
| CytoDyn | 357.29M |
| Northwest Biotherapeutics | 351.67M |